REFERENCES

1. Chapman AB, Zamudio S, Woodmansee W, et al. Systemic and renal hemodynamic changes in the luteal phase of the men­strual cycle mimic early pregnancy. Am J Physiol (Renal Physiol) 1997;273:F777-82.

2. Chapman AB, Abraham WT, Zamudio S, et al. Temporal rela­tionships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int 1998;54:2056-63.

3. Sturgiss SN, Dunlop W, Davison JM. Renal haemodynamics and tubular function in human pregnancy. Baillieres Clin Obstet Gynaecol 1994;8:2:209-34.

4. Faundes A, Bricola-Filho M, Pinto e Silva LC. Dilatation of the urinary tract during pregnancy: proposal of a curve of max­imal caliceal diameter by gestational age. Am J Obstet Gynecol 1998;178:1082-86.

5. Baba Y, Yamada T, Obata-Yasuoka M, et al. Urinary protein to cre­atinine ratio in pregnant women after dipstick testing: prospective observational study. BMC Pregnancy Childbirth 2015;15:331.

6. Davison JM, Shiells EA, Philips PR, Lindheimer MD. Serial evaluation of vasopressin release and thirst in human pregnancy. Role of human chorionic gonadotrophin in the osmoregulatory changes of gestation. J Clin Invest 1988;81:798-806.

7. Williams DJ, Metcalfe KA, Skingle L, Stock AI, Beedham T, Monson JP. Pathophysiology of transient cranial diabetes insip­idus during pregnancy. Clin Endocrinol 1993;38:595-600.

8. Steer PJ. Maternal haemoglobin concentration and birth weight. Am J Clin Nutr 2000;71 Suppl:1285S-87S.

9. Prentice A. Calcium in pregnancy and lactation. Annu Rev Nutr 2000;20:249-72.

10. Williams D, Davison JM. Chronic kidney disease in pregnancy. BMJ 2008;336:211-15.

11. Davidson NL, Wolski P, Callaway LK, et al. Chronic kidney dis­ease in pregnancy: maternal and fetal outcomes and progression of kidney disease. Obstet Med 2015;8:92-98.

12. Coomarasamy A, Honest H, Papaioannou S, Gee H, Khan KS.

13. Verdonk K, Niemeijer IC, Hop WC, et al Variation of urinary pro­tein to creatinine ratio during the day in women with suspected pre-eclampsia. BJOG 2014;121:1660-65.

14. Visintin C, Mugglestone MA, Almerie MQ, et al Management of hypertensive disorders during pregnancy: summary of NICE guidance. BMJ 2010;341:c2207.

15. Lopes van Balen VA, Spaan JJ, Cornelis T, Spaanderman MEA. Prevalence of chronic kidney disease after preeclampsia. J Nephrol 2017;30:403-409.

16. Berks D, Steegers EA, Molas M, Visser W Resolution of hyper­tension and proteinuria after preeclampsia. Obstet Gynecol 2009;114:1307-14.

17. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: system­atic review and meta-analysis. BMJ 2007;335:974.

18. Hypertension in pregnancy. Report of the American College of Obstetrics and Gynecologists’ task force on hypertension in preg­nancy. Obstet Gynecol 2013;122:1122-31.

19. Drakely AJ, Le Roux PA, Anthony J, Penny J. Acute renal failure complicating severe pre-eclampsia requiring admission to an ob­stetric intensive care unit. Am J Obstet Gynecol 2002;186:253-56.

20. Hildebrand AM, Liu K, Shariff SZ, et al. Characteristics and out­comes of AKI treated with dialysis during pregnancy and the postpartum period. J Am Soc Nephrol 2016;26:3085-91.

21. Tangren JS, Powe CE, Ankers E, et al. Pregnancy outcomes after clinical recovery from AKI. J Am Soc Nephrol 2017;28:1566-74.

22. Scully M, Cataland S, Coppo P, et al. Consensus on the standard­ization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies. J Thromb Haemost 2017;15:312-22.

23. Fakhouri F, Zuber J, Fremeaux-Bacchi V, Loirat C. Haemolytic ur­aemic syndrome. Lancet 2017;390:681-96.

24. Pauzner R, Dulitzky M, Carp H, et al. Hepatic infarctions during pregnancy are associated with the antiphospholipid syndrome and in addition with complete or incomplete HELLP syndrome.

25. Thomas MR, Robinson S, Scully MA. How we manage thrombotic microangiopathies in pregnancy. Br J Haematol 2016;173:821-30.

26. Prakash J, Singh VP. Changing picture of renal cortical necrosis in acute kidney injury in developing country. World J Nephrol 2015;4:480-86.

27. Frimat M, Decambron M, Lebas C, et al. Renal cortical necrosis in postpartum haemorrhage: a case series. Am J Kidney Dis 2016;68:50-57.

28. Woman Trial Collaborators. Effect of early tranexamic acid ad­ministration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an inter­national, randomised, double blind, placebo-controlled trial. Lancet 2017;389:2105-16.

29. Knight M, Nelson-Piercy C, Kurinczuk JJ, et al. A prospective national study of acute fatty liver of pregnancy in the UK. Gut 2008;57:951-56.

30. Yang Z, Zhao Y, Bennett MJ, Strauss AW, Ibdah JA. Fetal geno­types and pregnancy outcomes in 35 families with mitochon­drial trifunctional protein mutations. Am J Obstet Gynaecol 2002;187:715-20.

31. Carmelina G, Garovic VD, Gullo A, et al. Kidney injury during pregnancy: associated comorbid conditions and outcomes. Arch Gynecol Obstet 2012;286:567-73.

32. Semins MJ, Matlaga BR. Kidney stones during pregnancy. Nat Rev Urol 2014;11:163-68.

33. Masselli G, Weston M, Spencer J. The role of imaging in the diag­nosis and management of renal stone disease in pregnancy. Clin Radiol 2015;1462-71.

34. Zhang S, Liu G, Duo Y, et al. Application of ureteroscope in emer­gency treatment with persistent renal colic patients during preg­nancy. PLOS One 2016;11;e0146597.

35. Gregory MC, Mansell MA. Pregnancy and cystinuria. Lancet 1983;2:1158-60.

36. Hoeltzenbein M, Stieler K, Panse M, Wacker E, Schaefer C. Allopurinol use during pregnancy: outcome of 31 prospectively ascertained cases and a phenotype possibly indicative for terato­genicity. PLOS One 2013;8:e66637.

37. Khati NJ, Frazier AA, Brindle KA.

38. Wolff JM, Jung PK, Adam G, Jakse G. Non-traumatic rupture of the urinary tract during pregnancy. Br J Urol 1995;76:645-48.

39. Gait JE. Hemolytic reactions to nitrofurantoin in patients with glucose-6-phosphate dehydrogenase deficiency: theory and prac­tice. DICP 1990;24:1210-13.

40. Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA. Neural tube defects in relation to use of folic acid antagonists during pregnancy. Am J Epidemiol 2001;15:961-68.

41. Davenport M, Mach KE, Dairiki Shortliffe LM, et al. New and de­veloping diagnostic technologies for urinary tract infections. Nat Rev Urol 2017;14:296-310.

42. Rogozinska E, Formina S, Zamora J, et al. Accuracy of onsite tests to detect asymptomatic bacteriuria in pregnancy: a systematic re­view and meta-analysis. Obstet Gynecol 2016:128;495-503.

43. Kincaid Smith P, Bullen M. Bacteriuria in pregnancy. Lancet 1965;191:359-99.

44. Kazemier BM, Koningstein FN, Schneeberger C, et al. Maternal and neonatal consequences of treated and untreated asymptom­atic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infect Dis 2015;15:1324-33.

45. Smaill F. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev 2001;2;CD000490.

46. Romero R, Oyarzun E, Mazor M, et al. Meta-analysis of the rela­tionship between asymptomatic bacteriuria and preterm delivery/ low birth weight. Obstet Gynecol 1989;73:576-82.

47. Dwyer PL, O’Reilly M. Recurrent urinary tract infection in the female. Curr Opin Obstet Gynaecol 2002;14:537-43.

48. Wing DA, Fassett MJ, Getahun D. Acute pyelonephritis in preg­nancy: an 18-year retrospective analysis. Am J Obstet Gynecol 2014;210:219.e1-6.

49. Farkash E, Weintraub AY, Sergienko R, et al. Acute antepartum pyelonephritis in pregnancy: a critical analysis of risk factors and outcomes. Eur J Obstet Gynecol Reprod Biol 2012;162:24-27.

50. Duff P. Antibiotic selection in obstetrics: making cost-effective choices. Clin Obstet Gynaecol 2002;45:59-72.

51. Wing DA. Pyelonephritis in pregnancy. Treatment options for op­timal outcomes. Drugs 2001;61:2087-96.

52. Imbasciati E, Gregorinin G, Cabiddu G, et al. Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes. Am J Kidney Dis 2007;49:753-62.

53. Bramham K, Briley AL, Seed PT, et al. Pregnancy outcome in women with chronic kidney disease: a prospective cohort study. Reprod Sci 2011;18:623-30.

54. Munkhaugen J, Lydersen S, Romundstad PR, et al. Kidney func­tion and future risk for adverse pregnancy outcomes: a popula­tion-based study from HUNT II, Norway. Nephrol Dial Transplant 2009;24:3744-50.

55. Piccoli GB, Attini R, Vasario E, et al. Pregnancy and chronic kidney disease: a challenge in all CKD stages. Clin J Am Soc Nephrol 2010;5:844-55.

56. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO clinical practice guideline for the evalu­ation and management of chronic kidney disease. Kidney Int Suppl 2013;3:1-150.

57. Murakami S, Saitoh M, Kubo T, Koyama T, Kobayashi M. Renal disease in women with severe preeclampsia or gestational protein­uria. Obstet Gynecol 2000;96:945-49.

58. Jungers P, Chauveau D, Choukroun G, et al. Pregnancy in women with impaired renal function. Clin Nephrol 1997;47:281-88.

59. Cunningham FG, Cox SM, Harstad TW, Mason RA, Pritchard JA. Chronic renal disease and pregnancy outcome. Am J Obstet Gynecol 1990;163:453-59.

60. Jungers P, Houillier P, Forget D, et al. Influence of pregnancy on the course of primary chronic glomerulonephritis. Lancet 1995;346:1122-24.

61. Jones DC, Hayslett JP. Outcome ofpregnancy in women with mod­erate or severe renal insufficiency. N Eng J Med 1996;335:226-32.

62. Visintin C, Mugglestone MA, Almerie MQ, et al. Management of hypertensive disorders during pregnancy: summary of NICE guidance. BMJ 2010;341:c20207.

63. Packham DK, North RA, Fairley KF, et al.

64. Lupton M, Williams DJ. The ethics of research on pregnant women: is maternal consent sufficient? BJOG 2004;111:1307-12.

65. Wyatt RJ, Julian BA. IgA nephropathy. N Engl J Med 2013;368:2402-14.

66. Su X, Lv J, Liu Y, et al. Pregnancy and kidney outcomes in pa­tients with IgA nephropathy: a cohort study. Am J Kidney Dis 2017;70:262-69.

67. Liu Y, Ma X, Zheng J, Liu X, Yan T. A systematic review and meta­analysis of kidney and pregnancy outcomes in IgA nephropathy. Am J Nephrol 2016;44:187-93.

68. Ronkainen J, Nuutinen M, Koskimies O. The adult kidney 24 years after childhood Henoch-Schonlein purpura: a retrospective co­hort study. Lancet 2002;360:666-70.

69. Lech M, Anders H-J. The pathogenesis of lupus nephritis. J Am SocNephrol 2013;24:1357-66.

70. Wakasugi D, Gono T, Kawaguchi Y, et al. Frequency of class III and IV nephritis in systemic lupus erythematosus without clinical renal involvement: an analysis ofpredictive measures. J Rheumatol 2012;39:79-85.

71. Buyon JP, Kim MY, Guerra MM, et al. Predictors of pregnancy outcome in a prospective, multi-ethnic cohort of lupus patients. Ann Intern Med 2015; 163:153-63.

72. Buyon JP, Kim MY, Guerra MM, et al. Kidney outcomes and risk factors for nephritis (flare/de novo) in a multi-ethnic cohort of pregnant patients with lupus nephritis. Clin J Am Soc Nephrol 2017;12:940-46.

73. Moroni G, Doria A, Giglio E, et al. Maternal outcome in pregnant women with lupus nephritis. A prospective multicentre study. J Autoimmun 2016;74:194-200.

74. Bertsias GK, Tektonidou M, Amoura Z, et al. Joint European League Against Rheumatism and European Renal Association- European Dialysis and Transplant Association (EULAR/ERA- EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis 2012;71:1771-82.

75. Moroni G, Doria A, Giglio E, et al. Fetal outcomes and recom­mendations of pregnancies in lupus nephritis in the 21st century. A prospective multicentre study. J Autoimmunity 2016;74:6-12.

76. Flint J, Panchal S, Hurrell A, et al. BSR and BHPR guideline on pre­scribing drugs in pregnancy and breastfeeding - Part 1: standard and biologic disease modifying anti-rheumatic drugs and cortico­steroids. Rheumatology (Oxford) 2016;55:1693-97.

77. Fischer-Betz R, Specker C, Brinks R, et al. Low risk of renal flares and negative outcomes in women with lupus nephritis conceiving after switching from mycophenolate mofetil to azathioprine. Rheumatology 2013;52:1070-76.

78. Chapman AB, Johnson AM, Gabow PA. Pregnancy outcome and its relationship to progression of renal failure in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1994;5: 1178-85.

79. Torres VE, Chapman AB, Devuyst O, et al. Multicenter, open­label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 trial. Nephrol Dial Transplant 2018;33:477-89.

80. Jungers P, Houillier P, Chauveau D, et al. Pregnancy in women with reflux nephropathy. Kidney Int 1996;50:593-99.

81. North RA, Taylor RS, Gunn TR. Pregnancy outcome in women with reflux nephropathy and the inheritance of vesico-ureteric re­flux. AustN Z J Obstet Gynaecol 2000;40:280-85.

82. Collins AJ, Foley RN, Herzog C, et al. US Renal Data System 2010 Annual Data Report. Am J Kidney Dis 2011;57 1 Suppl 1:A8. e1-526.

83. Damm JA, Asbjornsdottir B, Callesen NF, et al. Diabetic nephrop­athy and microalbuminuria in pregnant women with type 1 and type 2 diabetes. Diabetes Care 2013:36:3489-94.

84. Nielsen LR, Muller C, Damm P, et al. Reduced prevalence of early preterm delivery in women with type 1 diabetes and microalbuminuria—possible effect of early antihypertensive treatment during pregnancy. Diabet Med 2006;23:426-31.

85. Klemetti MM, Laivouri H, Tikkanen M, et al. Obstetric and perinatal outcome in type 1 diabetes with diabetic nephropathy during 1988-2011. Diabetologia 2015;58:678-86.

86. Purdy LP, Hantsch CE, Molitch ME, et al. Effect of pregnancy on renal function in patients with moderate to severe diabetic renal insufficiency. Diabetes Care 1996;19:1067-74.

87. Hladunewich M, Schatell D. Intensive dialysis and pregnancy. Hemodial Int 2016;20:339-48.

88. Hladunewich M, Hou S, Odutayo A, et al. Intensive hemodi­alysis associates with improved pregnancy outcomes: a Canadian and United States cohort comparison. J Am Soc Nephrol 2014:25:1103-109.

89. Cabiddu C, Castellino S, Gernone G, et al. Best practices on preg­nancy on dialysis: the Italian study group on kidney and preg­nancy. JNephrol 2015:28:279-88.

90. Jesudason S, Grace BS, McDonald SP. Pregnancy outcomes ac­cording to dialysis commencing before or after conception in women with ESRD. Clin J Am Soc Nephrol 2014;9:143-49.

91. Coscia LA, Constantinescu S, Moritz MJ, et al. Report from the national transplantation pregnancy registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl 2010;7:65-85.

92. Richman K, Gohh R. Pregnancy after renal transplantation: a re­view of registry and single- centre practices and outcomes. Nephrol Dial Transplant 2012;27:3428-34.

93. Kim H, Jeong JC, Yang J, et al. The optimal therapy of calcineurin inhibitors for pregnancy in kidney transplantation. Clin Transplant 2015;29:142-48.

94. Kutzler HL, Ye X, Rochon C, martin ST. Administration of antithymocyte globulin (rabbit) to treat a severe mixed rejection episode in a pregnant renal transplant recipient. Pharmacotherapy 2016:36:e18-22.